Hemogenyx Pharmaceuticals PLC Tangible Net Worth Ratio
Hemogenyx Pharmaceuticals PLC tangible net worth ratio. Hemogenyx Pharmaceuticals PLC (HEMO) has a Tangible Net Worth Ratio of 44.1% as of December 2024. This metric is calculated by deducting intangible assets (GBX477.40K) from net assets (GBX853.49K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check HEMO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Hemogenyx Pharmaceuticals PLC (2015–2024)
Tangible net worth ratio of Hemogenyx Pharmaceuticals PLC from 2015 to 2024. This chart shows how Hemogenyx Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 9 annual periods from 2015 to 2024. As of December 2024, the ratio stands at 44.1%, reflecting net assets of GBX853.49K with intangible assets of GBX477.40K GBX. See working capital position of Hemogenyx Pharmaceuticals PLC to evaluate short-term liquidity relative to the company's equity base.
Hemogenyx Pharmaceuticals PLC Tangible Net Worth Ratio by Year (2015–2024)
Hemogenyx Pharmaceuticals PLC tangible net worth ratio by year from 2015 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see HEMO stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 44.1% | GBX853.49K | GBX477.40K | GBX4.21 Million | ▼ -39.0 pp |
| 2023 | 83.1% | GBX2.78 Million | GBX470.17K | GBX6.11 Million | ▼ -3.3 pp |
| 2022 | 86.4% | GBX3.24 Million | GBX441.49K | GBX7.09 Million | ▼ -8.2 pp |
| 2021 | 94.6% | GBX8.17 Million | GBX441.49K | GBX8.52 Million | ▲ +23.7 pp |
| 2020 | 70.9% | GBX875.68K | GBX254.96K | GBX2.66 Million | ▼ -0.7 pp |
| 2018 | 71.6% | GBX959.17K | GBX272.75K | GBX2.30 Million | ▼ -16.4 pp |
| 2017 | 87.9% | GBX2.13 Million | GBX257.52K | GBX2.40 Million | ▲ +19.1 pp |
| 2016 | 68.8% | GBX903.71K | GBX281.58K | GBX1.05 Million | ▲ +271.6 pp |
| 2015 | -202.8% | GBX77.82K | GBX235.64K | GBX324.65K | — |